Delivery Order SPE2DB20D2104-SPE2DB25FMTFD

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $1,075.37 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024 with a completion date of November 1, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $24,672.52 and a period of performance through February 26, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $12,193.62 firm fixed price contract has an ultimate completion date of April 23, 2024 and is not set aside for any small business designation. Amerisourcebergen is fulfilling this order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,613.14 and a completion date of May 31, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication, with a ceiling value of $5,946.37 and a completion date of May 21, 2025. The contract is a firm-fixed-price arrangement and is not set aside for any specific business size or type. AmerisourceBergen Drug Corp holds a...
This federal contract award is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award was made to the Amerisourcebergen Drug Corp, a major pharmaceutical supplier to the U.S. government. The contract has a ceiling value of $24,971.49 and is a Firm Fixed Price Delivery Order that will be completed by April 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,675.17 firm fixed-price delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $6,542.81. The ultimate completion date is May 22, 2025. Amerisourcebergen Drug Corp is the prime contractor and this award is a delivery order under the company's existing $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,582.14 delivery order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a completion date of March 19, 2025 and utilizes a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
The federal contract award summarized here is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $5,638.81 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 27, 2024, with a completion date of November 29, 2024. This contract is part of a larger Indefinite Delivery Contract...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMTFD
    Delivery Order

This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S medication to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order was awarded on June 12, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $9,705.23. The contract has an ultimate completion date of June 13, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs.

Generated 9/11/25, 10:51 AM